Reassessing pharmacological trials with positive composite outcome driven by reduction in nonfatal myocardial infarction: a systematic review and meta-analysis
Event:
ESC Congress 2024
Topic:
Trial Design
Session:
Cardiovascular trends: hospitalisations, trials, and genetic therapies
